Viewing Study NCT06825702


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-26 @ 2:33 AM
Study NCT ID: NCT06825702
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-02-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema
Sponsor: Kiora Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module